A full description of the SCTC Initiative is available at (http:// sctcresearch.org/PublicHome).
One common objective shared by Initiative components is to conduct research and disseminate findings on topics of high relevance for a wide array of audiences, including: tobacco control programmes; public health practitioners; researchers; and federal, state, and local policy makers. Initiative members engage in strategic partnerships with state and local tobacco control programmes and other voluntary health, advocacy and public health organisations. These partnerships help to assure the relevance of Initiative research, and facilitate rapid adoption of research findings into tobacco control policies and practices.
In 2013, the SCTC steering committee determined that priority audiences share an urgent need for high-quality, relevant research to inform state and community policies and practices related to electronic cigarettes (e-cigarettes) and related electronic nicotine delivery systems (ENDS). Collective SCTC research and dissemination resources and capabilities, guided by close partnerships with the tobacco control community, uniquely positions the The practice community's immediate need for high-quality scientific data to develop and implement effective policy and programmatic responses to a rapidly evolving ENDS environment was the primary stimulus for this supplement. The papers in this supplement. ▸ Provide detailed information on ENDS marketing through the internet and social media, and at the point of sale, as well as how tobacco users and nontobacco users are exposed to, search for, and share ENDS-related information across media platforms, ▸ Examine the patterns and reasons for e-cigarette use, including information about the impact of electronic cigarette use on vulnerable populations, such as those with mental health conditions. ▸ Summarise the current state-level ENDS policies. ▸ Investigate the impact of price and other tobacco control policies on ecigarette demand. These papers also contribute to the growing evidence base regarding marketing, use, and impact of ENDS in the USA that supports regulatory actions proposed by the Food and Drug Administration. 10 The range of ENDS research topics represented by the papers in this supplement is by no means exhaustive. The topics are necessarily biased towards the areas of focus for the SCTC Research Initiative; for example, high-priority topics, such as issues of harm reduction, product characterisation, health effects and toxicity, are generally not studied within the Initiative despite the research gaps. 11 12 Moreover, papers published here represent only a portion of the ENDS research being conducted by Initiative investigators, who will continue to publish findings from research on ENDS and other topics relevant to state and community tobacco control. 
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